|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beadsmoore CJ and Screaton NJ:
Classification, staging and prognosis of lung cancer. Eur J Radiol.
45:8–17. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papi A, Casoni G, Caramori G, Guzzinati I,
Boschetto P, Ravenna F, Calia N, Petruzzelli S, Corbetta L,
Cavallesco G, et al: COPD increases the risk of squamous
histological subtype in smokers who develop non-small cell lung
carcinoma. Thorax. 59:679–681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janssen-Heijnen ML and Coebergh JW: Trends
in incidence and prognosis of the histological subtypes of lung
cancer in North America, Australia, New Zealand and Europe. Lung
Cancer. 31:123–137. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Edwards BK, Brown ML, Wingo PA, Howe HL,
Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, et al:
Annual report to the nation on the status of cancer, 1975–2002,
featuring population-based trends in cancer treatment. J Natl
Cancer Inst. 97:1407–1427. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
International Early Lung Cancer Action
Program Investigators1, . Henschke CI, Yankelevitz DF, Libby DM,
Pasmantier MW, Smith JP and Miettinen OS: Survival of patients with
stage I lung cancer detected on CT screening. N Engl J Med.
355:1763–1771. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roth JA and Ramsey SD: Computed tomography
screening for lung cancer: A high-value proposition? JAMA.
315:77–78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sleeman MW, Wortley KE, Lai KM, Gowen LC,
Kintner J, Kline WO, Garcia K, Stitt TN, Yancopoulos GD, Wiegand SJ
and Glass DJ: Absence of the lipid phosphatase SHIP2 confers
resistance to dietary obesity. Nat Med. 11:199–205. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cutler RG, Kelly J, Storie K, Pedersen WA,
Tammara A, Hatanpaa K, Troncoso JC and Mattson MP: Involvement of
oxidative stress-induced abnormalities in ceramide and cholesterol
metabolism in brain aging and Alzheimer's disease. Proc Natl Acad
Sci USA. 101:2070–2075. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nguyen NT, Magno CP, Lane KT, Hinojosa MW
and Lane JS: Association of hypertension, diabetes, dyslipidemia,
and metabolic syndrome with obesity: Findings from the National
Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll
Surg. 207:928–934. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pendaries C, Tronchère H, Plantavid M and
Payrastre B: Phosphoinositide signaling disorders in human
diseases. FEBS Lett. 546:25–31. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ogretmen B and Hannun YA: Biologically
active sphingolipids in cancer pathogenesis and treatment. Nat Rev
Cancer. 4:604–616. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Görke R1, Meyer-Bäse A, Wagner D, He H,
Emmett MR and Conrad CA: Determining and interpreting correlations
in lipidomic networks found in glioblastoma cells. BMC Syst Biol.
4:1262010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee GK, Lee HS, Park YS, Lee JH, Lee SC,
Lee JH, Lee SJ, Shanta SR, Park HM, Kim HR, et al: Lipid MALDI
profile classifies non-small cell lung cancers according to the
histologic type. Lung Cancer. 76:197–203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suarna C, Dean RT, May J and Stocker R:
Human atherosclerotic plaque contains both oxidized lipids and
relatively large amounts of alpha-tocopherol and ascorbate.
Arterioscler Thromb Vasc Biol. 15:1616–1624. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyoshi N, Iwasaki N, Tomono S, Higashi T
and Ohshima H: Occurrence of cytotoxic 9-oxononanoyl secosterol
aldehydes in human low-density lipoprotein. Free Radic Biol Med.
60:73–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fhaner CJ, Liu S, Ji H, Simpson RJ and
Reid GE: Comprehensive lipidome profiling of isogenic primary and
metastatic colon adenocarcinoma cell lines. Anal Chem.
84:8917–8926. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ishikawa S, Tateya I, Hayasaka T, Masaki
N, Takizawa Y, Ohno S, Kojima T, Kitani Y, Kitamura M, Hirano S, et
al: Increased expression of phosphatidylcholine (16:0/18:1) and
(16:0/18:2) in thyroid papillary cancer. PLoS One. 7:e488732012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou X, Mao J, Ai J, Deng Y, Roth MR,
Pound C, Henegar J, Welti R and Bigler SA: Identification of plasma
lipid biomarkers for prostate cancer by lipidomics and
bioinformatics. PLoS One. 7:e488892012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu Z, Chen H, Ai J, Zhu Y, Li Y, Borgia
JA, Yang JS, Zhang J, Jiang B, Gu W and Deng Y: Global lipidomics
identified plasma lipids as novel biomarkers for early detection of
lung cancer. Oncotarget. 8:107899–107906. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Devaiah SP, Roth MR, Baughman E, Li M,
Tamura P, Jeannotte R, Welti R and Wang X: Quantitative profiling
of polar glycerolipid species from organs of wild-type Arabidopsis
and a phospholipase Dalpha1 knockout mutant. Phytochemistry.
67:1907–1924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith TC and Frank E: Introducing machine
learning concepts with WEKA. Springer; New York, NY: pp. 353–378.
2016
|
|
23
|
Weir IM, Wong G, Barlow CK, Greeve MA,
Kowalczyk A, Almasy L, Comuzzie AG, Mahaney MC, Jowett JB, Shaw J,
et al: Plasma lipid profiling in a large population-based cohort. J
Lipid Res. 54:2898–2908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolesnick R: Signal transduction through
the sphingomyelin pathway. Mol Chem Neuropathol. 21:287–297. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Green DR: Apoptosis and sphingomyelin
hydrolysis. The flip side. J Cell Biol. 150:F5–F7. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gangoiti P, Granado MH, Alonso A, Goñi FM
and Gomez-Munoz A: Implication of ceramide, ceramide 1-phosphate
and sphingosine 1-phosphate in tumorigenesis. Transl Oncogenomics.
3:81–98. 2008.PubMed/NCBI
|
|
27
|
Alberg AJ, Armeson K, Pierce JS, Bielawski
J, Bielawska A, Visvanathan K, Hill EG and Ogretmen B: Plasma
sphingolipids and lung cancer: A population-based, nested
case-control study. Cancer Epidemiol Biomarkers Prev. 22:1374–1382.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goldkorn T, Chung S and Filosto S: Lung
cancer and lung injury: The dual role of ceramide. Handb Exp
Pharmacol. 93–113. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goldkorn T and Filosto S: Lung injury and
cancer: Mechanistic insights into ceramide and EGFR signaling under
cigarette smoke. Am J Respir Cell Mol Biol. 43:259–268. 2010.
View Article : Google Scholar : PubMed/NCBI
|
